TELA Bio announced the U.S. launch of OviTex IHR Reinforced Tissue Matrix, specifically designed for use in laparoscopic and robotic-assisted inguinal hernia repair. OviTex IHR is available in three configurations, consisting of a three- or four-layer anatomically shaped device or a three-layer rectangular device, to provide surgeons with a variety of options to address unique patient, technique or procedure-related characteristics. This data includes a prior retrospective study, Minimizing Retained Foreign Body in Hernia Repair Using a Novel Technique: Reinforced Biologic Augmented Repair, examining OviTex Core Permanent in a variety of hernia repair techniques and indications. The study, led by Dr. Paul Szotek, Medical Director of the Indiana Hernia Center, included the analysis of 259 patients who underwent robotic inguinal hernia TAPP repair using the ReBAR technique and demonstrated a low 1.2% recurrence rate with an average follow up of 1.5 years.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TELA:
- TELA Bio Announces U.S. Commercial Launch of Robotic-Compatible OviTex® IHR – Addressing the Need for a More Natural Repair in Inguinal Hernia Procedures
- TELA Bio Welcomes Acclaimed Surgeon as Vice President of Medical Affairs and Surgeon Strategy
- Tela Bio appoints Howard Langstein as VP, medical affairs, surgeon strategy
- Tela Bio price target lowered to $12 from $15 at Piper Sandler
- TELA Bio Announces Investor Update and Hernia Mesh Launch
